Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.

Stopped early

Conditions studied: Airway Control

In brief

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Key facts

Study ID

NCT01486407

Run by

Vidacare Corporation

People needed

4

Starts

2012-02-01

Expected to finish

2012-12-01

Last updated by the study team

2026-01-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Requires rapid sequence intubation
• Succinylcholine is chosen paralytic agent
• Intravenous (IV) or Intraosseous (IO) access has been established for rapid sequence intubation
• For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO Rapid Sequence Intubation (RSI) case.

You may not qualify if…

• Vascular access other than IV or IO has been established

Where it is running

• Christus Spohn Hospital Corpus Christi — Corpus Christi, Texas, United States
• Texas Tech University Health Science Center El Paso — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.